RVL Pharmaceuticals plc Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD from Q1 2019 to Q4 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
RVL Pharmaceuticals plc quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate from Q1 2019 to Q4 2022.
- RVL Pharmaceuticals plc Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending December 31, 2022 was $93K, a 81.1% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Growth (%)